Your browser doesn't support javascript.
loading
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.
Schlenk, R F; Weber, D; Herr, W; Wulf, G; Salih, H R; Derigs, H G; Kuendgen, A; Ringhoffer, M; Hertenstein, B; Martens, U M; Grießhammer, M; Bernhard, H; Krauter, J; Girschikofsky, M; Wolf, D; Lange, E; Westermann, J; Koller, E; Kremers, S; Wattad, M; Heuser, M; Thol, F; Göhring, G; Haase, D; Teleanu, V; Gaidzik, V; Benner, A; Döhner, K; Ganser, A; Paschka, P; Döhner, H.
Afiliação
  • Schlenk RF; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany. richard.schlenk@nct-heidelberg.de.
  • Weber D; NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany. richard.schlenk@nct-heidelberg.de.
  • Herr W; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. richard.schlenk@nct-heidelberg.de.
  • Wulf G; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Salih HR; Department of Hematology, Medical Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany.
  • Derigs HG; Department of Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany.
  • Kuendgen A; Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany.
  • Ringhoffer M; Department of Internal Medicine III, Hospital Frankfurt-Hoechst, Frankfurt, Germany.
  • Hertenstein B; Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany.
  • Martens UM; Department of Hematology and Oncology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Grießhammer M; Department of Hematology and Oncology, Klinikum Bremen Mitte, Bremen, Germany.
  • Bernhard H; Department of Hematology and Oncology, Klinikum am Gesundbrunnen, Heilbronn, Germany.
  • Krauter J; Department of Hematology and Oncology, University Hospital of Minden, Minden, Germany.
  • Girschikofsky M; Department of Hematology and Oncology, University Hospital of Minden, Minden, Germany.
  • Wolf D; Department of Hematology and Oncology, Darmstadt, Municipal Hospital, Darmstadt, Germany.
  • Lange E; Department Hematology and Oncology, Braunschweig Municipal Hospital, Braunschweig, Germany.
  • Westermann J; Department of Hematology and Oncology, Hospital Elisabethinen Linz, Linz, Austria.
  • Koller E; Internal Medicine III, University Hospital of Bonn, Bonn, Germany.
  • Kremers S; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria.
  • Wattad M; Department of Hematology and Oncology, Evangelisches Krankenhaus Hamm, Hamm, Germany.
  • Heuser M; Department of Hematology, Oncology and Tumor Immunology, Charité - Campus Virchow Clinic, Berlin, Germany.
  • Thol F; Department of Internal Medicine III, Hanuschkrankenhaus Wien, Wien, Austria.
  • Göhring G; Department of Internal Medicine, Caritas-Krankenhaus Lebach, Lebach, Germany.
  • Haase D; Department of Hematology and Oncology, Hospital Essen-Werden, Essen, Germany.
  • Teleanu V; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Gaidzik V; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Benner A; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Döhner K; Department of Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany.
  • Ganser A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Döhner H; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.
Leukemia ; 33(8): 1923-1933, 2019 08.
Article em En | MEDLINE | ID: mdl-30728457
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha